RYBELSUS 7 MG TAB 30S: Balanced GLP-1 Analogue for Weight Management

Rybelsus 7mg is a GLP-1 receptor agonist (semaglutide) tablet taken once daily to improve blood sugar levels and support weight reduction in type 2 diabetes patients.

How It Works:

• Mounjaro mimics the natural glucagon-like peptide-1 (GLP-1) hormone.
• It increases insulin secretion when blood sugar levels are high, reduces glucagon production, slows gastric emptying, and helps regulate appetite.
• This dual action improves blood sugar control and may support gradual, safe weight loss.

Primary Use:

Mounjaro is primarily used for the management of type 2 diabetes mellitus. It also helps with weight reduction in patients with diabetes and reduces the risk of complications associated with high blood sugar.

Benefits:

• Promotes gradual and sustainable weight loss
• Enhances glycemic control in type 2 diabetes
• Reduces cardiovascular risk factors
• Improves adherence with once-daily oral administration

How to Use:

• Take exactly as prescribed by your doctor
• Swallow whole with water on an empty stomach
• Do not crush or chew the tablet
• Follow a balanced diet and exercise plan
• Regularly monitor blood sugar levels
• Contact your doctor if a dose is missed

Tips:

• Start at a lower dose and increase gradually to 7mg as advised
• Track your weight and blood sugar for best results
• Stay hydrated and avoid skipping meals

Side Effects:

Common side effects include nausea, vomiting, diarrhea, headache, dizziness, and mild injection site reactions such as redness or swelling. Serious but rare side effects may include pancreatitis, gallbladder issues, or kidney problems. Using Mounjaro with insulin or sulfonylureas may increase the risk of low blood sugar. Contact your doctor immediately if serious side effects occur.

Prescription Notice:

Prescription required for this medicine. Upload your prescription
No prescription? Book a consultation.
Rybelsus 7mg, a convenient oral GLP-1 analogue bridging effective glycemic control and weight management.